Company News
Dr Lal PathLabs Acquires 70% Stake in SN Genelab
Dr Lal PathLabs Board approved acquisition of 70% stake in SN Genelab for up to ₹168 crore plus performance-linked earnout.
SN Genelab operates in genomics diagnostics with turnover growing from ₹43.2
